Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmune hepatitis.

Ding-You Li1, Kathleen B Schwarz

  • 1Department of Pediatrics, Children's Mercy Hospital and University of Missouri, Kansas City School of Medicine, 64108, USA.

Adolescent Medicine Clinics
|July 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elevated serum aminotransferases in an infant with failure to thrive: A clinicopathological case report.

JPGN reports·2026
Same author

Epidemiologic Incentive to Eliminate Hepatitis C Virus in More Children.

JAMA network open·2026
Same author

Condition-Specific Growth Charts for Children With Alagille Syndrome.

JAMA network open·2025
Same author

Phenotypic Divergence of JAG1- and NOTCH2-Associated Alagille Syndrome & Disease-Specific NOTCH2 Variant Classification Guidelines.

Liver international : official journal of the International Association for the Study of the Liver·2025
Same author

Long-term efficacy and safety of sofosbuvir-based direct-acting antiviral regimens in paediatric patients with hepatitis C virus infection: an international registry study.

The Lancet. Child & adolescent health·2025
Same author

Sofosbuvir-velpatasvir in children 3-17 years old with hepatitis C virus infection.

Journal of pediatric gastroenterology and nutrition·2024
Same journal

Adolescent psychopharmacology: drugs for mood disorders.

Adolescent medicine clinics·2006
Same journal

Asperger's syndrome.

Adolescent medicine clinics·2006
Same journal

Prescription drug misuse: a growing national problem.

Adolescent medicine clinics·2006
Same journal

Abuse of proprietary (over-the-counter) drugs.

Adolescent medicine clinics·2006
Same journal

Performance-enhancing drug use in young athletes.

Adolescent medicine clinics·2006
Same journal

Tobacco use cessation for adolescents.

Adolescent medicine clinics·2006
See all related articles

Autoimmune hepatitis (AIH) diagnosis and treatment are discussed, considering factors like genetics and environment. New diagnostic criteria and a scoring system aid in identifying AIH types and de novo AIH in transplant patients.

Area of Science:

  • Hepatology
  • Immunology
  • Gastroenterology

Background:

  • Autoimmune hepatitis (AIH) is a complex liver disease affecting all ages, with a higher incidence in young girls.
  • The exact causes of AIH are still unknown, but genetic, environmental, and immune factors play a role.
  • Clinical presentation, susceptibility, and treatment responses in AIH vary based on individual factors.

Purpose of the Study:

  • To discuss the diagnosis and treatment of autoimmune hepatitis.
  • To review the three proposed types of AIH based on autoantibody profiles.
  • To address de novo autoimmune hepatitis in liver transplant recipients.

Main Methods:

  • Review of diagnostic criteria developed by an international panel.
  • Discussion of a proposed scoring system for AIH diagnosis.

Related Experiment Videos

  • Analysis of autoantibody profiles for AIH classification.
  • Main Results:

    • AIH diagnosis is aided by established criteria and a scoring system.
    • Three distinct types of AIH are recognized based on autoantibody profiles.
    • De novo AIH is a newly identified form in liver transplant recipients.

    Conclusions:

    • Accurate diagnosis of AIH is crucial for effective management.
    • Understanding AIH subtypes and de novo AIH improves patient care.
    • Multifactorial influences on AIH necessitate personalized treatment approaches.